Drugs that contain Deferasirox
1. Drug name - JADENU
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US9283209 | NOVARTIS PHARMS CORP | Oral formulations of deferasirox |
Nov, 2034
(12 years from now) | |
| CN105025886B | NOVARTIS PHARMS CORP | Oral Preparation Of Deferasirox (Deferasirox) |
Mar, 2034
(11 years from now) | |
| CN105025886A | NOVARTIS PHARMS CORP | Oral Preparation Of Deferasirox (Deferasirox) |
Mar, 2034
(11 years from now) | |
| EP3124018A1 | NOVARTIS PHARMS CORP | Oral Formulations Of Deferasirox |
Mar, 2034
(11 years from now) | |
| EP2964202A1 | NOVARTIS PHARMS CORP | Oral Formulations Of Deferasirox |
Mar, 2034
(11 years from now) | |
| EP2964202B1 | NOVARTIS PHARMS CORP | Oral Formulations Of Deferasirox |
Mar, 2034
(11 years from now) | |
| EP3124018B1 | NOVARTIS PHARMS CORP | Oral Formulations Of Deferasirox |
Mar, 2034
(11 years from now) | |
Treatment: NA
Dosage: TABLET;ORAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 90MG | TABLET;ORAL | Prescription |
| 180MG | TABLET;ORAL | Prescription |
| 360MG | TABLET;ORAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.